STAAR Surgical Co
Closed
SectorHealthcare
24.03 -0.37
Overview
Share price change
24h
Min
23.49
Max
25.33
Income | 5.2M 5.2M |
|---|---|
Sales | 36M 94M |
EPS | 0.29 |
Profit margin | 5.567 |
Employees | 921 |
EBITDA | 19M 10M |
Recommendations | Neutral |
|---|---|
12 Months Forecast | +21.96% upside |
Next Earnings | 12 Aug 2026 |
|---|
Market Cap | -243M 1.1B |
|---|---|
Previous open | 24.4 |
Previous close | 24.03 |
STAAR Surgical Co Chart
Past performance is not a reliable indicator of future results.
Related News
Peer Comparison
Price change
STAAR Surgical Co Forecast
Price Target
By TipRanks
21.96% upside
12 Months Forecast
Average 29.71 USD 21.96%
High 40 USD
Low 20 USD
Based on 9 Wall Street analysts offering 12 month price targets forSTAAR Surgical Co - Dist in the last 3 months.
Financials
Selling and administration expenses
Operating expenses
Pre-tax profit
Sales
Cost of sales
Gross profit on sales
Interest expense on debt
EBITDA
Operating profit
$
About STAAR Surgical Co
STAAR Surgical Company, together with its subsidiaries, designs, develops, manufactures, markets, and sells implantable lenses for the eye, and companion delivery systems to deliver the lenses into the eye. The company provides implantable Collamer lens product family (ICLs) to treat visual disorders, such as myopia, hyperopia, astigmatism, and presbyopia. It markets its products to health care providers, including ophthalmic surgeons, vision and surgical centers, hospitals, government facilities, and distributors, as well as products are primarily used by ophthalmologists. The company sells its products directly through its sales representatives in the United States, Japan, Germany, Spain, Canada, the United Kingdom, and Singapore, as well as through own representatives and independent distributors in China, Korea, India, France, Benelux, Italy, and internationally. STAAR Surgical Company was incorporated in 1982 and is headquartered in Lake Forest, California.
